|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/04 | |
| A61K 31/501 | |||
| A61P 3/04 | |||
| A61P 25/24 |
| (11) | Number of the document | 2280955 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09759417.0 |
| Date of filing the European patent application | 2009-06-04 | |
| (97) | Date of publication of the European application | 2011-02-09 |
| (45) | Date of publication and mention of the grant of the patent | 2017-10-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/046256 |
| Date | 2009-06-04 |
| (87) | Number | WO 2009/149258 |
| Date | 2009-12-10 |
| (30) | Number | Date | Country code |
| 58717 | 2008-06-04 | US |
| (72) |
QIU, Jun, US
GAO, Qi, US
LIU, Shuang, US
HU, Min, US
YANG, Yuh-lin, Allen, US
ISHERWOOD, Matthew, SG
AMIN, Rasidul, US
|
| (73) |
Albany Molecular Research, Inc.,
26 Corporate Circle, Albany, NY 12203,
US
|
| (54) | CRYSTALLINE FORM OF 6-[(4S)-2-METHYL-4-(2-NAPHTHYL)-1,2,3,4-TETRAHYDROISOQUINOLIN-7-YL]PYRIDAZIN-3-AMINE |
| CRYSTALLINE FORM OF 6-[(4S)-2-METHYL-4-(2-NAPHTHYL)-1,2,3,4-TETRAHYDROISOQUINOLIN-7-YL]PYRIDAZIN-3-AMINE |